Request Trial
shutterstock_1184108086_willy_barton
Willy Barton / Shutterstock.com
24 June 2021EuropeRory O'Neill

English High Court strikes out bad faith ‘Revolax’ TM

A Warrington-based distributor of aesthetic and cosmetic products has lost its UK trademark for a dermal filler brand after the English High Court found it to have registered the brand in bad faith.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Emotional Perception exclusive: ‘We are now very much open for business’
16 February 2026   Following the UK Supreme Court’s recent landmark judgment, which ushers in a sea-change to patent law, the team behind a groundbreaking AI-related invention sit down with Sarah Speight to explain how they got here, and why the ruling changes everything.
Europe
UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents
12 February 2026   The court has denied a German non-practising entity’s bid to secure unitary protection for a patent that it has asserted against Intel.
Europe
Reaction: Emotional Perception decision is ‘good for UK PLC’
12 February 2026   UK and European patent attorneys share their initial views after the UK Supreme Court delivered its landmark judgment, which “brings some much‑needed clarity and consistency” to the patentability of AI-related innovations—including those in the medtech industry.


Editor's picks

Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

Editor's picks

Americas
Novo Nordisk takes on Hims & Hers after $49 pill ‘turnaround’
10 February 2026

More features

Hogan Lovells makes senior public and administrative hire in Italy
Danaher moves to acquire Masimo in $9.9bn deal
Generic rival blocked as AZ defends diabetes stronghold
Emotional Perception exclusive: ‘We are now very much open for business’
New rankings recognise top US patent firms and lawyers
Norton Rose Fulbright expands pharma and biotech disputes team
UPC appeals court confirms ‘all-or-nothing’ rule for unitary patents
Honigman bags second Kirkland litigator this year for IP team